Probability of TCD-Normalization in the “Drepagreffe” Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels - Normandie Université Access content directly
Conference Papers Year : 2018

Probability of TCD-Normalization in the “Drepagreffe” Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels

P Chadebech
  • Function : Author
G Bodivit
  • Function : Author
A Jouard
  • Function : Author
S Verlhac
  • Function : Author
C Paillard
  • Function : Author
I Thuret
  • Function : Author
C Guitton
  • Function : Author
C Runel
  • Function : Author
F Missud
  • Function : Author
C Arnaud
  • Function : Author
A Kamdem
  • Function : Author
C Pondarré
  • Function : Author
F Pirenne
  • Function : Author
F Bernaudin
  • Function : Author
No file

Dates and versions

hal-02330827 , version 1 (24-10-2019)

Identifiers

  • HAL Id : hal-02330827 , version 1

Cite

Myriam Bernaudin, Yacine Khelif, P Chadebech, G Bodivit, A Jouard, et al.. Probability of TCD-Normalization in the “Drepagreffe” Trial Comparing Transplantation to Chronic Transfusion in Sickle Cell Anemia Children with Abnormal-Transcranial Doppler Is Associated with Lower Ang-2 and BDNF Plasma Levels. 60th ASH Annual Meeting, Dec 2018, San Diego, United States. (Sup 1) 506. ⟨hal-02330827⟩
16 View
0 Download

Share

Gmail Facebook X LinkedIn More